Finasteride Plus 1.25 mg Capsule, a) 30-count bottle, b) 90-count bottle, Compounded Product Not ...

FDA Drug Recall #D-1269-2020 — Class I — April 14, 2020

Recall Summary

Recall Number D-1269-2020
Classification Class I — Serious risk
Date Initiated April 14, 2020
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm MasterPharm LLC
Location South Richmond Hill, NY
Product Type Drugs
Quantity 7260 capsules

Product Description

Finasteride Plus 1.25 mg Capsule, a) 30-count bottle, b) 90-count bottle, Compounded Product Not for Resale, MasterPharm, 115-02 Liberty Ave, Richmond Hill, NY 11419.

Reason for Recall

Cross Contamination with Other Products; Finasteride Plus 1.25mg capsules were found to contain minoxidil.

Distribution Pattern

Nationwide in the U.S.

Lot / Code Information

Lot #02-27-2020:04@11, Exp. August 25, 2020.

Other Recalls from MasterPharm LLC

Recall # Classification Product Date
D-1424-2020 Class II Formula 82M (Minoxidil 5%/Tretinoin 0.01%/Fluoc... Jul 2, 2020
D-1428-2020 Class II Progesterone 150 mg Troche, 30 troches MasterPh... Jul 2, 2020
D-1431-2020 Class II Progesterone 200 mg Troche, 30 troches per bott... Jul 2, 2020
D-1420-2020 Class II Estriol 6 mg Capsule, 90 capsules per bottle, M... Jul 2, 2020
D-1434-2020 Class II Progesterone Modified Release 200 mg Capsule, 9... Jul 2, 2020

Frequently Asked Questions

Injectable drugs and eye drops must be completely free of microbial contamination because they bypass the body's natural defenses. A contaminated injectable can introduce bacteria or fungi directly into the bloodstream, potentially causing sepsis, meningitis, or localized infections — all of which can be life-threatening. Contamination of sterile products almost always results in a Class I recall. If you received an injectable drug from a recalled lot, contact your healthcare provider immediately, even if you feel well, as some infections can have delayed onset.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.